[AACR] Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer

meeteryu Post time 2024-2-26 20:15:26 | Show all posts |Read mode
Reward30points

journal£ºClinical Cancer Research

Authors£ºSomaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan; Elisa Fontana; Valentina Angerilli; Mia Delrieux; Daniel Nava Rodrigues; Letizia Procaccio; Sheela Rao; David Watkins; Naureen Starling; Ian Chau; Chiara Braconi; Nicos Fotiadis; Ruwaida Begum; Naomi Guppy; Louise Howell; Melanie Valenti; Scott Cribbes; Bernadett Kolozsvari; Vladimir Kirkin; Sara Lonardi; Michele Ghidini; Rodolfo Passalacqua; Raghad Elghadi; Luca Magnani; David J. Pinato; Federica Di Maggio; Filippo Ghelardi; Elisa Sottotetti; Guglielmo Vetere; Paolo Ciraci; Georgios Vlachogiannis; Filippo Pietrantonio; Chiara Cremolini; Alessio Cortellini; Fotios Loupakis; Matteo Fassan; Nicola Valeri

Published date£º--

DOI£º10.1158/1078-0432.ccr-23-2748

PDF link£ºhttps://aacrjournals.org/clincan ... 517/ccr-23-2748.pdf

Article link£ºhttp://dx.doi.org/10.1158/1078-0432.ccr-23-2748

Article Source£ºAmerican Association for Cancer Research (AACR)¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
hhthoj Post time 2024-2-26 20:15:27 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    3770

Latest Reply

Return to the list